NEXGEL, Inc.
NEXGEL, Inc. (NXGLW) Financial Performance & Income Statement Overview
Analyze NEXGEL, Inc. (NXGLW) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
NEXGEL, Inc. (NXGLW) Income Statement & Financial Overview
Explore comprehensive income reports for NEXGEL, Inc. NXGLW, broken down by year and quarter.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $2.94M | $1.44M | $1.27M | $1.08M |
| Cost of Revenue | $1.66M | $1.03M | $1.02M | $1.04M |
| Gross Profit | $1.28M | $410000.00 | $246000.00 | $40000.00 |
| Gross Profit Ratio | $0.44 | $0.28 | $0.19 | $0.04 |
| R&D Expenses | $0.00 | $76000.00 | $2000.00 | $13000.00 |
| SG&A Expenses | $2.07M | $1.39M | $1.11M | $1.25M |
| Operating Expenses | $2.07M | $1.46M | $1.12M | $1.26M |
| Total Costs & Expenses | $3.73M | $2.49M | $2.14M | $2.30M |
| Interest Income | $0.00 | $1000.00 | $0.00 | $0.00 |
| Interest Expense | $20000.00 | $30000.00 | $15000.00 | $2000.00 |
| Depreciation & Amortization | $184000.00 | $86000.00 | $114000.00 | $123000.00 |
| EBITDA | -$554000.00 | -$863000.00 | -$776000.00 | -$1.06M |
| EBITDA Ratio | -$0.19 | -$0.60 | -$0.60 | -$1.01 |
| Operating Income | -$788000.00 | -$1.05M | -$871000.00 | -$1.22M |
| Operating Income Ratio | -$0.27 | -$0.73 | -$0.69 | -$1.13 |
| Other Income/Expenses (Net) | $34000.00 | $75000.00 | -$34000.00 | $32000.00 |
| Income Before Tax | -$754000.00 | -$979000.00 | -$905000.00 | -$1.19M |
| Income Before Tax Ratio | -$0.26 | -$0.68 | -$0.71 | -$1.10 |
| Income Tax Expense | $0.00 | $0.00 | -$52000.00 | -$89000.00 |
| Net Income | -$693000.00 | -$885000.00 | -$853000.00 | -$1.10M |
| Net Income Ratio | -$0.24 | -$0.61 | -$0.67 | -$1.01 |
| EPS | -$0.11 | -$0.14 | -$0.14 | -$0.19 |
| Diluted EPS | -$0.11 | -$0.14 | -$0.14 | -$0.19 |
| Weighted Avg Shares Outstanding | $6.57M | $6.25M | $5.98M | $5.74M |
| Weighted Avg Shares Outstanding (Diluted) | $6.57M | $6.25M | $5.98M | $5.74M |
Over the past four quarters, NEXGEL, Inc. demonstrated steady revenue growth, increasing from $1.08M in Q4 2023 to $2.94M in Q3 2024. Operating income reached -$788000.00 in Q3 2024, maintaining a consistent -27% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$554000.00, reflecting operational efficiency. Net income rose to -$693000.00, with EPS at -$0.11. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan